The CURRENT-OASIS 7 reports criteria for severe bleeding associated with antiplatelet drug therapy.

CURRENT-OASIS 7 = Clopidogrel and aspirin optimal dose usage to reduce recurrent events - Seventh Organization to assess strategies in ischemic syndromes


Patient selection: therapy with clopidogrel and aspirin


Criteria for severe bleeding - one or more of the following:

(1) transfusion of >= 4 blood products

(2) hemoglobin drop >= 5 g/dL

(3) causes hypotension requiring inotropes

(4) results in surgery

(5) symptomatic intracranial hemorrhage

(6) death


Criteria for major bleeding:

(1) transfusion of 2-3 blood products

(2) intraocular bleeding with significant loss of vision

To read more or access our algorithms and calculators, please log in or register.